The global Nanomedicine Market was valued at USD 243.79 billion in 2024 and is expected to reach USD 270.96 billion by 2025. The industry is projected to grow significantly, hitting USD 459.83 billion by 2030 at a CAGR of 11.9% from 2025 to 2030. Its rapid expansion is fueled by advancements in targeted drug delivery, diagnostic innovations, AI-driven design optimization, and the rising demand for personalized medicine. Nanomedicine’s enhanced bioavailability, improved drug targeting, and controlled release mechanisms offer solutions to several challenges associated with traditional therapies, particularly in neurological and chronic disease treatments. Despite concerns related to toxicity, biocompatibility, and regulatory complexities, ongoing research, technological integration, and emerging clinical applications continue to strengthen the market outlook.